Biblio

Author Title [ Type

] Year

Filters: Author is Lu, Ying [Clear All Filters]

Journal Article

Wang H, Mao L, Yang M, Qian P, Lu H, Tong H, Xie W, Zhou D, Huang X, Wang Y, et al. Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial. Lancet Haematol. 2022.

Lin Q, Ye P, Wang T, Lu Y. Successful use of venetoclax combined with azacitidine in isolated extramedullary relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: a case report. Ann Hematol. 2023.

Yuan J, Pei R, Lu Y. Successful Haploidentical Hematopoietic Stem Cell Transplantation with Azacitidine and Venetoclax Maintenance Therapy for Acute Myeloid Leukemia with NUP98-RARG Gene Fusion. Turk J Haematol. 2022.

Ye P, Lin Q, Jin M, Gu X, Lu Y. Successful Allogenic Stem Cell Transplantation with Ruxolitinib Maintenance Therapy for Mutant Chronic Neutrophilic Leukemia Patient. Turk J Haematol. 2022.

Zhang X, Hou Z, Huang D, Wang F, Gao B, Zhang C, Zhou D, Lou J, Wang H, Gao Y, et al. Single-cell heterogeneity and dynamic evolution of Ph-like acute lymphoblastic leukemia patient with novel TPR-PDGFRB fusion gene. Exp Hematol Oncol. 2023;12(1):19.

Liu G-Y, Liu Y, Lu Y, Qin Y-R, Di G-H, Lei Y-H, Liu H-X, Li Y-Q, Wu C, Hu X-W, et al. Short-term memory of danger signals or environmental stimuli in mesenchymal stem cells: implications for therapeutic potential. Cell Mol Immunol. 2015.

Zhang C, Lu Y, Li Q, Mao J, Hou Z, Yu X, Fan S, Li J, Gao T, Yan B, et al. Salinomycin Suppresses TGF-β1-Induced Epithelial-to-Mesenchymal Transition in MCF-7 Human Breast Cancer Cells. Chem Biol Interact. 2016.

Liao J, Gong L, Xu Q, Wang J, Yang Y, Zhang S, Dong J, Lin K, Liang Z, Sun Y, et al. Revolutionizing Neurocare: Biomimetic Nanodelivery via Cell Membranes. Adv Mater. 2024:e2402445.

Zhang J, Liu D, Feng Z, Mao J, Zhang C, Lu Y, Li J, Zhang Q, Li Q, Li L. Retraction notice to "MicroRNA-138 modulates metastasis and EMT in breast cancer cells by targeting vimentin" [Biomed. Pharmacother. 77 (2016) 135-141]. Biomed Pharmacother. 2023:115372.

Gu L, Liu J, Xu D, Lu Y. Reciprocal Feedback Loop of the MALAT1-MicroRNA-194-YAP1 Pathway Regulates Progression of Acute Pancreatitis. Med Sci Monit. 2019;25:6894-6904.

Cao J, Pei R, Lu Y, Chen D, Du X, Liu X, Li S. The Proportion of Myeloid-derived Suppressor Cells in the Graft as a Potential Predictor of Acute Graft-versus-host Disease in Haploid Allogeneic Hematopoietic Stem Cell Transplantation. J Immunother. 2023.

Xia L, Liu J-Y, Yang M-Y, Zhang X-H, Jiang Y, Yin Q-Q, Luo C-H, Liu H-C, Kang Z-J, Zhang C-T, et al. Osimertinib covalently binds to CD34 and eliminates myeloid leukemia stem/progenitor cells. Cancer Res. 2023.

Chu CR, Rodeo S, Bhutani N, Goodrich LR, Huard J, Irrgang J, LaPrade RF, Lattermann C, Lu Y, Mandelbaum B, et al. Optimizing Clinical Use of Biologics in Orthopaedic Surgery: Consensus Recommendations From the 2018 AAOS/NIH U-13 Conference. J Am Acad Orthop Surg. 2018.

Cui Z, Xu Y, Wu P, Lu Y, Tao Y, Zhou C, Cui R, Li J, Han R. NAT10 promotes osteogenic differentiation of periodontal ligament stem cells by regulating VEGFA-mediated PI3K/AKT signaling pathway through ac4C modification. Odontology. 2023.

Zhang G, Lu Y, Song J, Huang D, An M, Chen W, Han P, Yao X, Zhang X. A multifunctional nano-hydroxyapatite/MXene scaffold for the photothermal/dynamic treatment of bone tumours and simultaneous tissue regeneration. J Colloid Interface Sci. 2023;652(Pt B):1673-1684.

Ye P, Pei R, Jin J, Sun J, Li K, Cao J, Zhou D, Lu Y. Modified cladribine, cytarabine, and G-CSF as a salvage regimen in patients with relapsed/refractory acute myeloid leukemia: a bridge to myeloablative allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2019.

Wu D, Zhang J, Lu Y, Bo S, Li L, Wang L, Zhang Q, Mao J. miR-140-5p inhibits the proliferation and enhances the efficacy of doxorubicin to breast cancer stem cells by targeting Wnt1. Cancer Gene Ther. 2018.

Cao J, Xu X, Lu Y, Wang T, Chen D, Li S, Liu X, Ye P, Zheng Z-Z, Pei R. Intensified conditioning regimen with fludarabine combined with post-transplantation cyclophosphamide for haploidentical allogeneic hematopoietic stem cell transplantation in children with high-risk acute leukemia. Hematology. 2023;28(1):2223873.

Lu Y, Zhang C, Li Q, Mao J, Ma W, Yu X, Hou Z, Li L. [Inhibitory effect of salinomycin on human breast cancer cells MDA-MB-231 proliferation through Hedgehog signaling pathway]. Zhonghua Bing Li Xue Za Zhi. 2015;44(6):395-398.

Di G-H, Liu Y, Lu Y, Liu J, Wu C, Duan H-F. IL-6 Secreted from Senescent Mesenchymal Stem Cells Promotes Proliferation and Migration of Breast Cancer Cells. PLoS One. 2014;9(11):e113572.

Ye P, Pei R, Lian J, Chen D, Li S, Cheng Y, Li F, Yuan J, Chen Y, Lu Y. Higher efficacy of Etoposide + Cytarabine Plus Pegfilgrastim in poorly mobilizing Multiple Myeloma and lymphoma Patients. Cytotherapy. 2023.

Cao J, Pei R, Lu Y, Zheng Z, Yuan Z, Li D, Zhang P, Liu X, Chen D, Du X, et al. Fludarabine and antithymocyte globulin-based conditioning regimen combined with post-transplantation cyclophosphamide for haploidentical allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia and myelodysplast. Curr Res Transl Med. 2022;71(1):103360.

Liu X, Lu Y, Xu Y, Hou S, Huang J, Wang B, Zhao J, Xia S, Fan S, Yu X, et al. Exosomal transfer of miR-501 confers doxorubicin resistance and tumorigenesis via targeting of BLID in gastric cancer. Cancer Lett. 2019.

Cao J, Li A, Pei R, Lu Y, Chen D, Du X, Liu X, Li S, Ye P. Effectiveness of single-dose 6 mg pegfilgrastim in mobilizing peripheral blood stem cells in allogeneic hematopoietic cell transplantation donors. Ann Hematol. 2023.

Yang J, Ran K, Ma W, Chen L, Chen C, Zhang C, Ye H, Lu Y, Ran C. Degradation of amyloid beta species by multi-copper oxidases. bioRxiv. 2023.

Pages